Author

A. M. Greene

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:non-human primate· 2 Assay:proteomics· 2 Research Focus:cell-cell communication· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

G. Smith· 2 shared M. Guebre-Xabier· 2 shared N. Patel· 2 shared A. D. Portnoff· 1 shared A. M. Marchese· 1 shared A. Zhu· 1 shared B. Zhou· 1 shared C. Atyeo· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

G. Smith

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

XBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants

N. Patel, J. F. Trost, M. Guebre-Xabier, H. Zhou, J. Norton, D. Jiang, Z. Cai, M. Zhu, A. M. Marchese, A. M. Greene, R. M. Mallory, R. Kalkeri, F. Dubovsky, G. Smith

This study shows that a monovalent XBB.1.5 spike protein vaccine induces broader neutralizing antibodies and stronger cellular immunity against multiple SARS-CoV-2 variants compared to bivalent vaccines.

bioRxiv · Aug 30, 2023Immunology

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination

M. J. Gorman, N. Patel, M. Guebre-Xabier, A. Zhu, C. Atyeo, K. Pullen, C. Loos, Y. Goez-Gazi, R. Carrion, J.-H. Tian, D. Yuan, K. Bowman, B. Zhou, S. Maciejewski, M. McGrath, , G. Alter

This study shows that NVX-CoV2373 vaccine induces antibodies with both neutralizing and Fc-effector functions, which together provide maximal protection against SARS-CoV-2 in non-human primates.

bioRxiv · Feb 5, 2021 · PreprintImmunology